PRISCILA Precision risk stratification in pregnancy and postpartum in women with gestational diabetes
- Coordinator
- Katholieke Universiteit Leuven, Belgium
- Runs
- 1 January 2027 to 31 December 2031
- Status
- Running
- EU funding
- €1.9m
- Total cost
- €1.9m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101299462
What the project is doing
In the project's own words, from its summary on CORDIS.
Gestational diabetes mellitus is the most frequent medical complication in pregnancy, increasing the risk of other pregnancy complications, and leading to increased cardio-metabolic risk in the long-term for mother and child. The current management strategy for GDM is one-size-fits-all, despite the heterogeneity of GDM etiology. Moreover, current risk stratification strategies have limited value to inform clinical decisions.
Detailed characterization of etiological subtypes of GDM are of paramount importance (1) to understand the underlying pathophysiology for differential risk for complications and (2) to inform precision approaches for risk stratification and management of GDM. I hypothesize that a careful characterization of different GDM subtypes through integration by artificial intelligence (AI) computation of a comprehensive dataset of clinical and biochemical characteristics, continuous glucose monitoring (CGM) data, novel biomarkers, metabolomics, polygenic risk scores, diet, physical activity, mental health, sleep quality and breastfeeding, a novel risk stratification will be discovered.
In the PRISCILA project, I will therefore enrol a large cohort of GDM patients’, whereby prospective collection of consolidated and innovative potential risk predictors will take place in pregnancy and postpartum, in order to generate an unprecedented multidimensional dataset and allowing for patients deep phenotyping. I will analyse data leveraging AI computation to find relevant associations with clinical outcomes, and compare new algorithms with current stratification strategies.
This project will provide important novel knowledge on the differences in characteristics, pathophysiology and risk for complications across different GDM subtypes. If successful, it will allow for a paradigm shift in how clinicians, policymakers and patients can better tailor the management strategy for GDM.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Katholieke Universiteit Leuven | Leuven | Belgium | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI